Commentary Open Access
Volume 2 | Issue 4 | DOI: https://doi.org/10.33696/immunology.2.032
CRISPR Taking the Front Seat in Immunotherapy
Saad S. Kenderian1,2,3,4, Andrew D. Badley4,5,*
- 1T Cell Engineering, Mayo Clinic, Rochester, MN, USA
- 2Division of Hematology, Mayo Clinic, Rochester, MN, USA
- 3Department of Immunology, Mayo Clinic, Rochester, MN, USA
- 4Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA
- 5Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA
Corresponding Author
Andrew Badley, badley.andrew@mayo.edu
Received Date: February 07, 2020
Accepted Date: May 04, 2020
Citation:
Kenderian SS, Badley AD. CRISPR Taking the Front Seat in Immunotherapy. J Cell Immunol. 2020; 2(4): 143-148.
Copyright: © 2020 Kenderian SS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.